KPC-Producing Extreme Drug-Resistant Klebsiella pneumoniae Isolate from a Patient with Diabetes Mellitus and Chronic Renal Failure on Hemodialysis in South Korea
- 1 May 2010
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (5), 2278-2279
- https://doi.org/10.1128/aac.00011-10
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Emergence in Italy of Klebsiella pneumoniae Sequence Type 258 Producing KPC-3 CarbapenemaseJournal of Clinical Microbiology, 2009
- First isolations of KPC-2-carrying ST258 Klebsiella pneumoniae strains in Finland, June and August 2009Eurosurveillance, 2009
- Emergence of Klebsiella pneumoniae ST258 with KPC-2 in PolandAntimicrobial Agents and Chemotherapy, 2009
- Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258Antimicrobial Agents and Chemotherapy, 2009
- Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USAJournal of Antimicrobial Chemotherapy, 2009
- Metallo-β-lactamase VIM-2 in Pseudomonas aeruginosa isolates from a cystic fibrosis patientInternational Journal of Antimicrobial Agents, 2008
- A Step Closer to Extreme Drug Resistance (XDR) in Gram-Negative BacilliClinical Infectious Diseases, 2007
- Multilocus Sequence Typing of Klebsiella pneumoniae Nosocomial IsolatesJournal of Clinical Microbiology, 2005
- CTX-M and SHV-12 β-lactamases are the most common extended-spectrum enzymes in clinical isolates ofEscherichia coliandKlebsiella pneumoniaecollected from 3 university hospitals within KoreaFEMS Microbiology Letters, 2005
- Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain ofKlebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2001